News
RXRX ▲ +0.3% - Recursion Pharmaceuticals, Inc.
RXRX ▲ +0.3% - Recursion Pharmaceuticals, Inc.
$RXRX - Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
15-OCT-2026 08:45 AM ET
Share this post
More filings for $RXRX
RXRX ▼ -5.0% - Recursion Pharmaceuticals, Inc.Nov 2, 2026RXRX ▼ -5.5% - Recursion Pharmaceuticals, Inc.Nov 2, 2026RXRX ▼ -5.7% - Recursion Pharmaceuticals, Inc.Nov 2, 2026RXRX ▼ -5.5% - Recursion Pharmaceuticals, Inc.Nov 2, 2026RXRX ▲ +3.0% - Recursion Pharmaceuticals, Inc.Oct 26, 2026RXRX ▼ -4.0% - Recursion Pharmaceuticals, Inc.Oct 15, 2026
View full $RXRX filing history →💬 Comments
Loading comments…
Leave a comment